Confronta i metodi
Esamina i metodi selezionati fianco a fianco; le righe che differiscono sono evidenziate.
| MMAT× | PRISMA Checklist× | |
|---|---|---|
| Campo | Metodologia della ricerca | Metodologia della ricerca |
| Famiglia | Process / pipeline | Process / pipeline |
| Anno di origine≠ | 2014 (updated 2018) | 2021 (original 2009) |
| Ideatore≠ | Pluye et al. | Page et al. (PRISMA Group) |
| Tipo≠ | Research methodology evaluation | Systematic review author reporting checklist |
| Fonte seminale≠ | Pluye, P., & Hong, Q. N. (2014). Combining the power of stories and the power of numbers: mixed methods research and mixed studies reviews. Annual Review of Public Health, 35, 29–45. DOI ↗ | Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., ... & Moher, D. (2021). The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ, 372, n71. DOI ↗ |
| Alias | MMAT, MMAT 2018 | PRISMA, PRISMA 2020 |
| Correlati | 4 | 4 |
| Sintesi≠ | MMAT (Mixed Methods Appraisal Tool) is a practical, design-agnostic quality assessment tool developed by Pluye et al. (2014, updated 2018) to evaluate the methodological quality of quantitative (RCTs, non-randomized studies), qualitative, and mixed-methods studies. Unlike tools designed for single paradigms (e.g., Cochrane RoB 2 for RCTs), MMAT provides unified criteria applicable across diverse research methodologies, making it particularly useful for systematic reviews incorporating multiple study designs. | PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) is a 27-item evidence-based checklist published in 2021 (updated from 2009) to standardize reporting of systematic reviews and meta-analyses. Endorsed by over 500 journals, PRISMA is the international standard for evidence synthesis reporting, used across healthcare, psychology, education, and social sciences to ensure transparency and reproducibility. |
| ScholarGateInsieme di dati ↗ |
|
|